Amphastar Pharmaceuticals (AMPH) Change in Taxes (2013 - 2017)

Amphastar Pharmaceuticals' Change in Taxes history runs 5 years deep, the most recent figure standing at -$2.5 million for Q3 2017.

• On a quarterly basis, Change in Taxes fell 351.29% year-over-year to -$2.5 million in Q3 2017; TTM through Sep 2017 was -$5.8 million, a 236.88% decrease from a year earlier, with the FY2015 full-year figure at -$92000.0, down 116.46% from the prior year.
• Change in Taxes improved to -$2.5 million in Q3 2017 per AMPH's latest filing, from -$3.2 million in the prior quarter.
• Across five years, Change in Taxes topped out at $6.0 million in Q4 2014 and bottomed at -$5.4 million in Q3 2014.
• The 5-year median for Change in Taxes is -$154000.0 (2014), against an average of -$314500.0.
• Across the five-year window, Change in Taxes surged 15137.5% in 2014 and slumped 351.29% in 2017, its largest moves.
• Year by year, Change in Taxes stood at -$40000.0 in 2013, then jumped by 15137.5% to $6.0 million in 2014, then slumped by 83.52% to $991000.0 in 2015, then sank by 154.89% to -$544000.0 in 2016, then slumped by 351.29% to -$2.5 million in 2017.
• Per Business Quant, the three latest AMPH Change in Taxes figures stand at -$2.5 million (Q3 2017), -$3.2 million (Q2 2017), and $394000.0 (Q1 2017).